BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38838507)

  • 1. Rupatadine inhibits colorectal cancer cell proliferation through the PIP5K1A/Akt/CDK2 pathway.
    Jiang L; Zhang Z; Luo Z; Li L; Yuan S; Cui M; He K; Xiao J
    Biomed Pharmacother; 2024 Jul; 176():116826. PubMed ID: 38838507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 4. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
    Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
    Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of long non-coding RNA RP11-708H21.4 is associated with poor prognosis for colorectal cancer and promotes tumorigenesis through regulating AKT/mTOR pathway.
    Sun L; Jiang C; Xu C; Xue H; Zhou H; Gu L; Liu Y; Xu Q
    Oncotarget; 2017 Apr; 8(17):27929-27942. PubMed ID: 28427191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spica prunellae promotes cancer cell apoptosis, inhibits cell proliferation and tumor angiogenesis in a mouse model of colorectal cancer via suppression of stat3 pathway.
    Lin W; Zheng L; Zhuang Q; Zhao J; Cao Z; Zeng J; Lin S; Xu W; Peng J
    BMC Complement Altern Med; 2013 Jun; 13():144. PubMed ID: 23800091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
    Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
    Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual PI3K-BRD4 Inhibitor SF1126 Inhibits Colorectal Cancer Cell Growth in Vitro and in Vivo.
    Qin AC; Li Y; Zhou LN; Xing CG; Lu XS
    Cell Physiol Biochem; 2019; 52(4):758-768. PubMed ID: 30933440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delicaflavone induces ROS-mediated apoptosis and inhibits PI3K/AKT/mTOR and Ras/MEK/Erk signaling pathways in colorectal cancer cells.
    Yao W; Lin Z; Shi P; Chen B; Wang G; Huang J; Sui Y; Liu Q; Li S; Lin X; Liu Q; Yao H
    Biochem Pharmacol; 2020 Jan; 171():113680. PubMed ID: 31669234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyshikonin isolated from
    Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X
    Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505
    [No Abstract]   [Full Text] [Related]  

  • 16. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. uc.338 targets p21 and cyclin D1 via PI3K/AKT pathway activation to promote cell proliferation in colorectal cancer.
    Zhang Y; Wang S; Qian W; Ji D; Wang Q; Zhang Z; Wang S; Ji B; Fu Z; Sun Y
    Oncol Rep; 2018 Aug; 40(2):1119-1128. PubMed ID: 29901203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/ GSK3β/cyclin D1 pathway.
    Wang J; Li XM; Bai Z; Chi BX; Wei Y; Chen X
    J Ethnopharmacol; 2018 Jan; 210():1-9. PubMed ID: 28684297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
    Ding C; Li L; Yang T; Fan X; Wu G
    BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.
    Cao LJ; Liu LY; Chen YQ; Han YY; Wei LH; Yao MY; Fang Y; Wu MZ; Cheng Y; Sferra TJ; Liu HX; Li L; Peng J; Shen AL
    Chin J Integr Med; 2024 Jun; 30(6):515-524. PubMed ID: 38216838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.